JPS4921147B1 - - Google Patents
Info
- Publication number
- JPS4921147B1 JPS4921147B1 JP12760870A JP12760870A JPS4921147B1 JP S4921147 B1 JPS4921147 B1 JP S4921147B1 JP 12760870 A JP12760870 A JP 12760870A JP 12760870 A JP12760870 A JP 12760870A JP S4921147 B1 JPS4921147 B1 JP S4921147B1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Plural Heterocyclic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12760870A JPS4921147B1 (enExample) | 1970-12-28 | 1970-12-28 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12760870A JPS4921147B1 (enExample) | 1970-12-28 | 1970-12-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS4921147B1 true JPS4921147B1 (enExample) | 1974-05-30 |
Family
ID=14964284
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP12760870A Pending JPS4921147B1 (enExample) | 1970-12-28 | 1970-12-28 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS4921147B1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10064869B2 (en) | 2014-06-04 | 2018-09-04 | Thomas Helledays Stiftelse For Medicinsk Forskning | MTH1 inhibitors for treatment of inflammatory and autoimmune conditions |
-
1970
- 1970-12-28 JP JP12760870A patent/JPS4921147B1/ja active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10064869B2 (en) | 2014-06-04 | 2018-09-04 | Thomas Helledays Stiftelse For Medicinsk Forskning | MTH1 inhibitors for treatment of inflammatory and autoimmune conditions |
| US10632125B2 (en) | 2014-06-04 | 2020-04-28 | Thomas Helledays Stiftelse For Medicinsk Forskning | MTH1 inhibitors for treatment of inflammatory and autoimmune conditions |